Thalidomide Derived Immunomodulatory Drugs (IMiDs) as Potential Therapeutic Agents
Journal:
Current Drug Targets - Immune, Endocrine & Metabolic Disorders
Volume:
3
Page:
181-186
Author(s):
J Blake Marriott, Keith Dredge and Angus G. Dalgleish
Emerging Features in the Regulation of MMP-9 Gene Expression for the Development of Novel Molecular Targets and Therapeutic Strategies
Journal:
Current Drug Targets - Inflammation & Allergy
Volume:
2
Page:
206-215
Author(s):
Yves St-Pierre, Celine Van Themsche and Pierre-Olivier Esteve
Pharmacophores for Ligand Recognition and Activation / Inactivation of the Cannabinoid Receptors
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1607-1633
Author(s):
Patricia H. Reggio
Radiation and Gene Therapy: Rays of Hope for the New Millennium?
Journal:
Current Gene Therapy
Volume:
3
Page:
319-339
Author(s):
M. Boyd, H. S. Spenning and R. J. Mairs
Hexokinase II: The Integration of Energy Metabolism and Control of Apoptosis
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
1535-1551
Author(s):
John G. Pastorino and Jan B. Hoek
The Peripheral Benzodiazepine Receptor: A Promising Therapeutic Drug Target
Journal:
Current Medicinal Chemistry
Volume:
10
Page:
1563-1572
Author(s):
Sylvaine Galiegue, Norbert Tinel and Pierre Casellas
Inhibitors of the Proteolytic Activity of Urokinase Type Plasminogen Activator
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1483-1498
Author(s):
Todd W. Rockway and Vincent L. Giranda
Structure-Function Relationships in the Interaction Between the Urokinase- Type Plasminogen Activator and Its Receptor
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1499-1528
Author(s):
Michael Ploug
Urokinase-type Plasminogen Activator (uPA) and its Receptor (uPAR): Development of Antagonists of uPA / uPAR Interaction and their Effects In Vitro and In Vivo
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1529-1543
Author(s):
Ute Reuning, Stefan Sperl, Charlotte Kopitz, Horst Kessler, Achim Kruger, Manfred Schmitt and Viktor Magdolen
Plasminogen Activator Inhibitor-1 in Tumor Growth, Angiogenesis and Vascular Remodeling
Journal:
Current Pharmaceutical Design
Volume:
9
Page:
1545-1564
Author(s):
Steingrimur Stefansson, Grainne A. McMahon, Eric Petitclerc and Daniel A. Lawrence